Research programme: Proto oncogene protein-c bcl-2 inhibitors - Kirin Brewery

Drug Profile

Research programme: Proto oncogene protein-c bcl-2 inhibitors - Kirin Brewery

Alternative Names: 1133719

Latest Information Update: 11 Jul 2007

Price : $50

At a glance

  • Originator Kirin Brewery
  • Class Small molecules
  • Mechanism of Action Apoptosis stimulants; Proto-oncogene protein c-bcl-2 inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • No development reported Cancer

Most Recent Events

  • 22 Jul 2003 Preclinical trials in Cancer in Japan (unspecified route)
  • 22 Jul 2003 Data presented at the 94th Annual Meeting of the American Association for Cancer Research (AACR-2003) have been added to the Cancer pharmacodynamics section
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top